Show simple item record

dc.contributor.authorSchnittman, Samuel R.
dc.contributor.authorByakwaga, Helen
dc.contributor.authorBoum, Yap
dc.contributor.authorKabakyenga, Jerome
dc.contributor.authorMatthews, Lynn T.
dc.contributor.authorBurdo, Tricia H.
dc.contributor.authorHuang, Yong
dc.contributor.authorTracy, Russell P.
dc.contributor.authorHaberer, Jessica E.
dc.contributor.authorKembabazi, Annet
dc.contributor.authorKaida, Angela
dc.contributor.authorMoisi, Daniela
dc.contributor.authorLederman, Michael M.
dc.contributor.authorBangsberg, David R.
dc.contributor.authorMartin, Jeffrey N.
dc.contributor.authorHunt, Peter W.
dc.date.accessioned2022-01-31T11:20:44Z
dc.date.available2022-01-31T11:20:44Z
dc.date.issued2021
dc.identifier.citationSchnittman, S. R., Byakwaga, H., Boum, Y., Kabakyenga, J., Matthews, L. T., Burdo, T. H., ... & Hunt, P. W. (2021, June). Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection. In Open forum infectious diseases (Vol. 8, No. 6, p. ofab245). US: Oxford University Press. DOI: 10.1093/ofid/ofab245en_US
dc.identifier.other10.1093/ofid/ofab245
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1662
dc.description.abstractPregnant women with HIV (PWWH) have high postpartum morbidity and mortality from infections like tuberculosis. Immunologic changes during pregnancy and postpartum periods may contribute to these risks, particularly the immunoregulatory kynurenine pathway of tryptophan catabolism, which contributes to both HIV and tuberculosis pathogenesis and increases in the early postpartum period. Women with HIV initiating antiretroviral therapy (ART) in the Uganda AIDS Rural Treatment Outcomes (UARTO) cohort who were pregnant at enrollment or became pregnant during observation were studied (n = 54). Plasma kynurenine/tryptophan (KT) ratio, soluble CD14 (sCD14), sCD163, sCD27, interferon-inducible protein 10 (IP-10), D-dimer, interleukin-6, and intestinal fatty-acid binding protein levels were assessed through the first year of ART and at 3-month intervals throughout pregnancy and 1 year postpartum. Biomarker changes were assessed with linear mixed models adjusted for ART duration. Hemoglobin concentration changes were used to estimate pregnancy-related changes in plasma volume. Results. The median pre-ART CD4 count was 134. D-dimer increased through the third trimester before returning to baseline postpartum, while most other biomarkers declined significantly during pregnancy, beyond what would be expected from pregnancy associated plasma volume expansion. IP-10 and sCD14 remained suppressed for at least 12 months postpartum. KT ratio was the only biomarker that increased above prepregnancy baseline postpartum (mean + 30%; P < .001) and remained higher than baseline for ≥9 months (P ≤ .045 for all time points). Several immune activation markers decline during pregnancy and remain suppressed postpartum, but the kynurenine pathway of tryptophan catabolism increases above baseline for ≥9 months postpartum. The mechanisms underlying postpartum kynurenine pathway activity are incompletely understood but may contribute to increased tuberculosis risk in this setting.en_US
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.subjectHIVen_US
dc.subjectIndoleamine 2en_US
dc.subject3-dioxygenase-1en_US
dc.subjectInflammationen_US
dc.subjectKynurenine/tryptophan ratioen_US
dc.subjectPregnancy.en_US
dc.titleChanges in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infectionen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record